BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 19, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 18, 2021
View Archived Issues
PDAC priming boosts chemotherapeutic efficacy
Read More
IEM presents new antiparkinsonian compounds
Read More
Discovery of novel peptides that upregulate costimulatory and checkpoint pathways
Read More
Janssen Pharmaceutica patents MGLL inhibitors
Read More
Roche discloses new compounds for E. coli infections
Read More
Immunome details activity of anti-IL-38 monoclonal antibody IMM-20324
Read More
Gritscience Biopharmaceuticals identifies casein kinase 1 isoform delta inhibitors
Read More
VX-01, a humanized antibody with protective effects against murine mucormycosis
Read More
AstraZeneca synthesizes new cannabinoid CB1 receptor antagonists
Read More
Farsight Medical Technology synthesizes PPIA and PPIF inhibitors
Read More
PRT-2527 shows efficacy in models of hematological and solid tumors with MYC dysregulation
Read More
A phosphatidylserine-containing nanoparticle platform for oral prophylactic reverse vaccination
Read More
Dual MEK inhibitor IMM-1-104 may be an improvement over approved MEK inhibitors
Read More
NMPA accepts IND for Simcere's anti-TNFR2 antibody SIM-0235
Read More
Plasma and tissue FGL1 expression is increased in patients with Crohn's disease
Read More
Ipsen collaborates with Accent Therapeutics on preclinical METTL3 inhibitor program
Read More
Targinta selects TARG-10 as lead drug candidate for triple-negative breast cancer
Read More
PAT-DX3-MMAE significantly increases survival in animal model of breast cancer
Read More
TechnoPhage identifies therapeutic antibody for COVID-19
Read More